Monthly Archives: February 2012

MagForce AG Successfully Completes Capital Increase

Posted: Published on February 29th, 2012

About MagForce AG: MagForce AG is a leading medical technology company focusing on nanomedicine in oncology. The company`s proprietary procedure, NanoTherm therapy, enables the targeted treatment of solid tumors through the intratumoral generation of heat via activation of magnetic nanoparticles. NanoTherm, NanoPlan, and NanoActivator(TM) are components of the therapy and have received EU-wide regulatory approval as medical devices for the treatment of brain tumors. MagForce, NanoTherm, NanoPlan and NanoActivator are trademarks of MagForce AG in selected countries. For more information, please visit http://www.magforce.com. Disclaimer: This release may contain forward-looking statements and information which may be identified by formulations using terms such as "expects", "aims", "anticipates", "intends", "plans", "believes", "seeks", "estimates" or "will". Such forward-looking statements are based on our current expectations and certain assumptions, which may be subject to a variety of risks and uncertainties. The results actually achieved by MagForce AG may substantially differ from these forward-looking statements. MagForce AG assumes no obligation to update these forward-looking statements or to correct them in case of developments, which differ from those, anticipated. Contact: Stacy Wiedenmann Director Investor Relations & Corporate Communications Magforce AG Max-Dohrn-Str. 8 10589 Berlin T +49 30 308 380 31 F +49 30 308 380 99 M … Continue reading →

Comments Off on MagForce AG Successfully Completes Capital Increase

Nanostart-holding MagForce AG Successfully Completes Capital Increase

Posted: Published on February 29th, 2012

FRANKFURT & BERLIN--(BUSINESS WIRE)-- Nanostart (OTCQX: NASRF.PK - News) -holding MagForce AG (Frankfurt, XETRA: MF6), a leading medical technology company focusing on nanomedicine in oncology has completed a share placement with institutional investors. All of the 825,408 newly issued shares were placed, with profit participation rights dating from January 1, 2011, at a price of EUR 5.50 per share. The gross proceeds from the capital increase, in the amount of EUR 4,539,744.00 will be used for further commercialization activities and the clinical development of the NanoTherm technology along with the expansion of commercial and strategic partnerships. This transaction increases the nominal share capital of the company, from EUR 4.127.041, divided into 4,127,041 shares with an imputed nominal value of EUR 1.00, to EUR 4,952,495.00. To support the transaction, Nanostart AG as the major shareholder of the company, signed a lock-up which indicates that Nanostart AG will sell no shares of MagForce AG over the stock exchange within the next twelve months. The capital increase and the meetings with the strategic investors were managed by Silvia Quandt & Cie. AG as a tied agent as defined in 2 paragraph 10 of the Banking Act (KWG) and called on account of biw … Continue reading →

Comments Off on Nanostart-holding MagForce AG Successfully Completes Capital Increase

International Cellular Medicine Society Grants First Worldwide Accreditation to Tijuana Clinical Trial

Posted: Published on February 29th, 2012

Regenerative Medicine Institute, Mexico has been granted full accreditation for its clinical stem cell trials Portland, Oregon (PRWEB) February 29, 2012 We are pleased that RMI undertook this process, says David Audley, executive director of the ICMS. The clinic understood that patient safety can only be assured through strict evaluation and rigorous oversight. From day one they have embraced the transparency that this program requires. RMI is the first clinic to achieve this status under the ICMS Accreditation Program. The clinic has undergone two separate site audits as well as an institutional review board review evaluation. Most importantly, the clinic has placed in excess of 50 patients into the Treatment Registry for long-term outcome tracking. The safety profile has been excellent, continued Audley. We have tracked patients over at least two follow-ups and a minimum of six months and not seen a single cell-related adverse event. The ICMS is currently evaluating nearly a dozen clinics worldwide. Accreditation is based upon the Guidelines for the Practice of Cell-Based Medicine developed and published by the ICMS. Key components of these guidelines are the ethical recruitment of patients, proper consent of patients and compliance with local laws and regulations in the treatment of … Continue reading →

Posted in Mesenchymal Stem Cells | Comments Off on International Cellular Medicine Society Grants First Worldwide Accreditation to Tijuana Clinical Trial

Stem Cell Pioneers Converge in Portland to Discuss and Celebrate a Revolutionary New Stem Cell Entering Human Clinical …

Posted: Published on February 29th, 2012

SAN DIEGO, CA and PORTLAND, OR--(Marketwire -02/28/12)- Medistem Inc. (Pinksheets: MEDS.PK - News) announced today its Annual "Evening with Medistem" Event will take place in Portland, Oregon on March 7th, 2012. The event is being hosted by Vladimir Zaharchook, Vice Chairman at Medistem, Inc., and will feature stem cell luminaries and pioneers working with Medistem including Dr. Amit Patel, Director of Regenerative Medicine at University of Utah and the first person to administer stem cells into patients with heart failure, Dr. Michael Murphy, Vascular Surgeon at Indiana University and Principal Investigator for Medistem's FDA clinical trial in patients with risk of amputation, and Dr. Alan Lewis, former CEO of the Juvenile Diabetes Research Foundation, advisory board member of Medistem. In 2007 Medistem discovered an entirely new type of stem cell, the Endometrial Regenerative Cell (ERC). This cell has proven it is a "universal donor" and can be used to treat many more conditions compared to other types of stem cells. The company received FDA clearance to begin clinical trials in September of 2011 for critical limb ischemia, a condition that is associated with amputation. Medistem is also running a Phase II clinical trial for heart failure using the new stem … Continue reading →

Posted in Mesenchymal Stem Cells | Comments Off on Stem Cell Pioneers Converge in Portland to Discuss and Celebrate a Revolutionary New Stem Cell Entering Human Clinical …

Iranian researcher discovers factor of stem cell disorder

Posted: Published on February 29th, 2012

Source: ISNA, Tehran The researches have studied mesenchymal stem cells or MSCs derived from mice bone marrow in cell culture period and succeeded to identify new division in cell latency period which can lead to chromosomal disorders in the cells. Phd student in Hematology at Tarbiat Modarres University in Tehran, Naser Ahmad Beigi told ISNA that mesenchymal stem cells are powerful tools in cell therapeutic and tissue engineering because of their special specifications. For the same reasons stem cells derived from them are used effectively in experiments. He added during the procedure of separating mesenchymal stem cells from mice bone marrows, many researchers believe them to be dead and refuse to continue the procedure and this is because of changing form of the cells and a reduction in their propagation at the beginning level of the cell culture. Beigi stressed these signs show latency period and that cells would be propagated without showing any signs for a long time if the culture continues. He noted an unknown division is the specification of the latency period which leads to chromosomal disorders. He added the disorders can lead to the appearance of tumors inside the body and inefficiency of non-carcinogenic drugs and … Continue reading →

Posted in Mesenchymal Stem Cells | Comments Off on Iranian researcher discovers factor of stem cell disorder

International Cellular Medicine Society Grants First Worldwide Accreditation to Tijuana Clinical Trial

Posted: Published on February 29th, 2012

Regenerative Medicine Institute, Mexico has been granted full accreditation for its clinical stem cell trials Portland, Oregon (PRWEB) February 29, 2012 We are pleased that RMI undertook this process, says David Audley, executive director of the ICMS. The clinic understood that patient safety can only be assured through strict evaluation and rigorous oversight. From day one they have embraced the transparency that this program requires. RMI is the first clinic to achieve this status under the ICMS Accreditation Program. The clinic has undergone two separate site audits as well as an institutional review board review evaluation. Most importantly, the clinic has placed in excess of 50 patients into the Treatment Registry for long-term outcome tracking. The safety profile has been excellent, continued Audley. We have tracked patients over at least two follow-ups and a minimum of six months and not seen a single cell-related adverse event. The ICMS is currently evaluating nearly a dozen clinics worldwide. Accreditation is based upon the Guidelines for the Practice of Cell-Based Medicine developed and published by the ICMS. Key components of these guidelines are the ethical recruitment of patients, proper consent of patients and compliance with local laws and regulations in the treatment of … Continue reading →

Comments Off on International Cellular Medicine Society Grants First Worldwide Accreditation to Tijuana Clinical Trial

Stem Cell Therapy Procedure and Outcome – Video

Posted: Published on February 29th, 2012

28-02-2012 14:48 Albert Rodriguez, MD administers stem cell therapy for Hereditary Spastic Paraplegia. stemcelldrR.com, email airpainmd@aol.com Original post: Stem Cell Therapy Procedure and Outcome - Video … Continue reading →

Comments Off on Stem Cell Therapy Procedure and Outcome – Video

Statins get new safety warnings

Posted: Published on February 29th, 2012

New labels on statins will warn of rare, but potentially serious, side effects. (Bob Chamberlin / Los Angeles Times) February 28, 2012, 3:51 p.m. The agency announced it would require improved safety warning labels on statins to warn of the rare risk of liver damage, memory loss and other cognitive problems and increases in blood sugar that can lead to Type 2 diabetes. Moreover, the drug known as lovastatin (which is known by several brand names, including Mevacor) can cause muscle weakness in rare cases. The new warnings are not likely to cause doctors to pull their patients off the medications. Many questions remain about how rare these risks actually are and whether they are more common after many years of use or in certain individuals. The agency eased up on one warning associated with statins. The labels will no longer advise doctors to routinely monitor liver enzymes of patients taking statins. The updated wording on the label will state that liver enzyme tests should be performed when a patient first begins taking statins and when indicated thereafter. The main intent of the label change is to inform consumers of any risks associated with the drugs, according to the FDA. … Continue reading →

Posted in Drug Side Effects | Comments Off on Statins get new safety warnings

New face of drug use – Baby Boomers

Posted: Published on February 29th, 2012

by KING 5 HealthLink KING5.com Posted on February 28, 2012 at 5:49 PM Peggy is 58 years old, and in drug rehab for the first time. Although alcohol remains the most popular addiction for Baby Boomers, there has been a dangerous spike with illegal drugs, not to mention prescription medications, which become easier to get at this age as patients develop more aches and pains. "Doctors are quick to prescribe them for pain, people find comfort in them. And they're off and running, they abuse them, they develop a dependency, they wind up at our front door." Stan Galperson, Tarzana Treatment Center Galperson runs a residential and out-patient treatment center. He says part of the challenge for the over-50 crowd is simply lifestyle. At this point, if they are nearing retirement they have some money, more time and less structure. "You don't have the consequences anymore that the boss may notice that you are under the influence, your work performance is suffering. If you don't have those anymore it is quite easy to let your addiction progress, said Galperson. And when kids leave the nest, many moms and dads simply feel lost. "Substance use becomes an alternative to deal with … Continue reading →

Posted in Drug Dependency | Comments Off on New face of drug use – Baby Boomers

Nadia Lockyer's ex-lover: 'There's a way bigger story than the sex tapes'

Posted: Published on February 29th, 2012

The man at the center of the drug-infused, sex-laced scandal that has rocked the political careers and shaky marriage of state Treasurer Bill Lockyer and his wife, Nadia, strode into a San Jose courtroom Tuesday, his hair slick, his shirt untucked and told a reporter, "There's a way bigger story than the sex tapes." Before he had a chance to explain much more, his private defense attorney interrupted: "Do you want me to be your lawyer?" It was Adrienne Dell, a no-nonsense lawyer in a St. John Knit, telling him to clam up. Stephen Chikhani, 35, with wraparound dark glasses and a soul patch under his lip, stopped talking after that. It was the first comment from either Alameda County Supervisor Nadia Lockyer or Chikhani about the rumored existence of a sex tape. Chikhani, who has faced drug charges a number times over the past decade, was in Santa Clara County Superior Court on Tuesday after a California Highway Patrol officer pulled him over on Stevens Creek Boulevard in San Jose in September and allegedly found a bag of methamphetamine in his maroon 2003 Nissan 350Z. He faces four charges: possession of methamphetamine, being under the influence of a controlled … Continue reading →

Posted in Drug Dependency | Comments Off on Nadia Lockyer's ex-lover: 'There's a way bigger story than the sex tapes'